Grail Inc (GRAL) Stock Price, Quote & News

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 833 694 2553

Website: grail.com

Address:

1525 O’Brien Drive, Menlo Park, United States

sam92 Mar. 20 at 1:28 PM

$GRAL 02:47 PM EDT, 03/18/2026 (MT Newswires) -- Grail (GRAL) shares rose 6.1% in Wednesday trading after TD Cowen upgraded the stock to buy from hold while lowering the price target to $65 from $114.

0 · Reply

Chipmonk1 Mar. 19 at 6:00 PM

$GRAL Just heard grail is changing it’s name to FOR SALE Great name

0 · Reply

Bazzzigar Mar. 19 at 4:42 PM

$GRAL HIMS BBNX

0 · Reply

TheUnmaker Mar. 19 at 4:07 PM

$TNXP I'm waiting for my $GRAL type run on this. Ran $GRAL from under $30 to $115+. I'm considering $HSCS soon also to run through when the time is right. Potential $30 squeeze play.

0 · Reply

RunnerSignals Mar. 18 at 8:37 PM

$NRG $CF $GRAL $KNX $MAN Top stock upgrades today in the BUZZ https://stocksrunner.com/news/2026-03-18-top-stock-upgrades-today-in-the-buzz

0 · Reply

AStrokeOfLuck Mar. 18 at 5:26 PM

$GRAL Nice, but PT sucks

0 · Reply

SM07 Mar. 18 at 3:15 PM

$GRAL SP to hit $54 today

0 · Reply

MantasTrades Mar. 18 at 3:12 PM

$GRAL 👏🏻🔥 MORREEEEEEEE

0 · Reply

NxtMill Mar. 18 at 2:37 PM

$GRAL cancer screening in hims cost 750 that is too much

0 · Reply

notreload_ai Mar. 18 at 12:32 PM

TD Cowen upgrades $GRAL to Buy from Hold with $65 target after 60% selloff. Analyst sees attractive entry in multi-cancer detection despite NHS study miss. https://notreload.xyz/td-cowen-turns-bullish-on-grail/

0 · Reply

Grail CEO Bob Ragusa to retire, Josh Ofman named successor

Mar 12, 2026, 4:30 PM EDT - 9 days ago

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

Mar 5, 2026, 9:00 AM EST - 16 days ago

Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

Mar 2, 2026, 4:01 PM EST - 19 days ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 24, 2026, 4:02 PM EST - 25 days ago

GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 9:29 AM EST - 26 days ago

GRAIL Stock Tumbles — National Health Service Galleri Trial To Blame

Feb 23, 2026, 9:06 AM EST - 26 days ago

'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection

Feb 20, 2026, 4:26 PM EST - 4 weeks ago

This once-hot cancer-detection company's stock got cut in half after a failed trial

Feb 20, 2026, 8:35 AM EST - 4 weeks ago

Grail shares plunge after major cancer screening trial misses main goal

Feb 20, 2026, 4:06 AM EST - 4 weeks ago

Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame.

Feb 19, 2026, 9:27 PM EST - 4 weeks ago

Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 19, 2026, 9:25 PM EST - 4 weeks ago

GRAIL, Inc. (GRAL) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:02 PM EST - 4 weeks ago

GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 19, 2026, 4:01 PM EST - 4 weeks ago

Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

Feb 16, 2026, 9:00 AM EST - 4 weeks ago

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

Jan 29, 2026, 7:25 PM EST - 7 weeks ago

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

Jan 26, 2026, 8:00 AM EST - 7 weeks ago

A Study on Aging Unlocks Holy Grail of Sports Performance

Jan 20, 2026, 8:34 AM EST - 2 months ago

GRAIL Inc. - Illumina's Divested Holy Grail

ILMN

Jan 12, 2026, 1:16 PM EST - 2 months ago

GRAIL, Inc. (GRAL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 15, 2025, 4:01 PM EST - 3 months ago

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 24, 2025, 9:11 AM EST - 4 months ago

Deutsche Bank may have just set a holy-grail goal for the S&P 500

DB IVV SPXL SPY SSO UPRO VOO

Nov 18, 2025, 4:02 PM EST - 4 months ago

GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 13, 2025, 12:58 PM EST - 4 months ago

Grail Q3 Earnings: Massive Stock Gains, Mediocre Performance - I'm Still Not Sold

Nov 12, 2025, 6:21 PM EST - 4 months ago

GRAIL, Inc. (GRAL) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 4:02 PM EST - 4 months ago

GRAIL Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 4:02 PM EST - 4 months ago

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Nov 4, 2025, 3:15 PM EST - 4 months ago

Top Biotech Stocks Riding The Rally

CTMX GRFS INCY

Oct 29, 2025, 4:02 PM EDT - 5 months ago

GRAIL to Announce Third Quarter 2025 Financial Results

Oct 27, 2025, 7:00 AM EDT - 5 months ago

GRAIL: Buy Τhe Test That Could Redefine Cancer Screening

Oct 22, 2025, 8:05 PM EDT - 5 months ago

Odds of these speculative stocks making you money seems very slim, says Jim Cramer

ASTS TGEN TMQ AUR RGTI

Oct 20, 2025, 5:05 PM EDT - 5 months ago

GRAIL, Inc. (GRAL) Discusses PATHFINDER 2 Study Results and Clinical Program in Multi-Cancer Early Detection Transcript

Oct 20, 2025, 6:30 AM EDT - 5 months ago

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

Oct 20, 2025, 6:00 AM EDT - 5 months ago

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

Oct 17, 2025, 6:08 PM EDT - 5 months ago

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

Oct 17, 2025, 9:55 AM EDT - 5 months ago

What's Happening With GRAIL Stock?

Oct 16, 2025, 8:22 AM EDT - 5 months ago

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Sep 30, 2025, 12:17 PM EDT - 6 months ago

Grail: A Speculative Buy

Sep 23, 2025, 9:01 AM EDT - 6 months ago

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

Sep 19, 2025, 8:47 AM EDT - 6 months ago

Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry

Sep 10, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 9, 2025, 5:31 PM EDT - 6 months ago

GRAIL, Inc. (GRAL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 28, 2025, 6:20 AM EDT - 7 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR ILMN IONS MRNA RGEN

Aug 26, 2025, 4:02 PM EDT - 7 months ago

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 12, 2025, 7:13 PM EDT - 7 months ago

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:02 PM EDT - 7 months ago

GRAIL Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:02 PM EDT - 8 months ago

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

sam92 Mar. 20 at 1:28 PM

0 · Reply

Chipmonk1 Mar. 19 at 6:00 PM

$GRAL Just heard grail is changing it’s name to FOR SALE Great name

0 · Reply

Bazzzigar Mar. 19 at 4:42 PM

$GRAL HIMS BBNX

0 · Reply

TheUnmaker Mar. 19 at 4:07 PM

$TNXP I'm waiting for my $GRAL type run on this. Ran $GRAL from under $30 to $115+. I'm considering $HSCS soon also to run through when the time is right. Potential $30 squeeze play.

0 · Reply

RunnerSignals Mar. 18 at 8:37 PM

$NRG $CF $GRAL $KNX $MAN Top stock upgrades today in the BUZZ https://stocksrunner.com/news/2026-03-18-top-stock-upgrades-today-in-the-buzz

0 · Reply

AStrokeOfLuck Mar. 18 at 5:26 PM

$GRAL Nice, but PT sucks

0 · Reply

SM07 Mar. 18 at 3:15 PM

$GRAL SP to hit $54 today

0 · Reply

MantasTrades Mar. 18 at 3:12 PM

$GRAL 👏🏻🔥 MORREEEEEEEE

0 · Reply

NxtMill Mar. 18 at 2:37 PM

$GRAL cancer screening in hims cost 750 that is too much

0 · Reply

notreload_ai Mar. 18 at 12:32 PM

0 · Reply

ByBi Mar. 17 at 10:45 PM

$TNXP $GRAL $HSCS $BCDA Agreed. Tnxp long term downtrend reversing seem here. This swing trade heading to low 100's if it does. One of the best 2026 potential out there imo. 👀👀👀

1 · Reply

TheUnmaker Mar. 17 at 8:49 PM

$TNXP If you connect a descending trend line from the top of the candle on 12/17/24 and connect it to the top of the candle on 8/14/25 you will see that it descends down to todays top price. Between $12.80 and $15.45 is a strong demand zone. We are nearing a breakout if this buying zone remains. I want my $59 gap fill. Loading for the long haul on this sleeper! $GRAL $HSCS $BCDA

0 · Reply

Coinbit Mar. 17 at 1:50 PM

$GRAL $ 50 today

0 · Reply

Bazzzigar Mar. 16 at 6:41 PM

$GRAL few more

0 · Reply

Coinbit Mar. 16 at 5:04 PM

$GRAL 55 by the end of march just watch it happening

0 · Reply

Chipmonk1 Mar. 16 at 2:16 PM

$GRAL GRAIL up for sale? I heard either Dollar General or the Dollar tree wants to buy them. They think it’s a good fit for their people when they come in the store. Sounds good to me after going down 50% in one day I think either one of those two companies would be a good fit for this piece of shit Company

0 · Reply

Coinbit Mar. 16 at 3:01 AM

$GRAL 48-49 Monday closing price

0 · Reply

JaredSotken Mar. 16 at 2:40 AM

$GRAL Maybe wait a bit longer?

0 · Reply

bonniewinter Mar. 15 at 8:48 PM

$GRAL Added shared at $42.50; thanks for the opportunity. I believe GRAL will succeed with FDA approval based on safety & clinical validity of its test, its first mover status and significant benefit with stage 4 cancer reduction which is being validated via REACH trial in US Medicare population. A lot has been invested in this science for the bigger good of humanity.

0 · Reply

Snowbird99 Mar. 14 at 8:39 PM

$GRAL Picked some up at 41.70 lets see what happens next week

0 · Reply

QuantInsider Mar. 14 at 3:12 PM

$GRAL taking a beating after the Galleri trial flop Down over 13% in the past week and another 2.9% today This isn't the time to try fading it The selling pressure is real and there's no sign of stabilization yet Options flow is light Just one stale sweep of March 20 $70 calls before the trial news No fresh bullish conviction here If you're thinking about jumping in, be cautious with liquidity and exits Respect the downside momentum

0 · Reply

Chipmonk1 Mar. 13 at 7:48 PM

$GRAL told all of you Chapter 7 coming. SP down 28 days

0 · Reply

Market Cap	1.99B
Revenue (ttm)	147.17M
Net Income (ttm)	-408.35M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-277.47%
Debt to Equity Ratio	0.00

Volume	1,200,300
Avg Vol	1,412,500
Day's Range	N/A - N/A
Shares Out	41.02M
Stochastic %K	53%
Beta	5.18
Analysts	Strong Sell
Price Target	$83.40